Lucas Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$823K Buy
+22,371
New +$821K 0.96% 30
2019
Q1
Sell
-10,796
Closed -$447K 55
2018
Q4
$447K Buy
+10,796
New +$448K 0.59% 43
2018
Q3
Sell
-10,574
Closed -$364K 83
2018
Q2
$364K Buy
10,574
+211
+2% +$7.21K 0.34% 58
2018
Q1
$349K Sell
10,363
-289
-3% -$9.94K 0.34% 58
2017
Q4
$366K Sell
10,652
-1,172
-10% -$40K 0.32% 62
2017
Q3
$400K Sell
11,824
-448
-4% -$14.4K 0.36% 56
2017
Q2
$391K Sell
12,272
-185
-1% -$5.83K 0.28% 76
2017
Q1
$404K Hold
12,457
0.3% 70
2016
Q4
$384K Sell
12,457
-158
-1% -$4.82K 0.28% 73
2016
Q3
$405K Sell
12,615
-738
-6% -$24.7K 0.31% 65
2016
Q2
$446K Sell
13,353
-1,054
-7% -$33.6K 0.32% 67
2016
Q1
$405K Hold
14,407
0.3% 72
2015
Q4
$441K Sell
14,407
-995
-6% -$31.3K 0.28% 76
2015
Q3
$459K Buy
15,402
+77
+0.5% +$2.47K 0.27% 76
2015
Q2
$488K Buy
15,325
+421
+3% +$13.7K 0.22% 86
2015
Q1
$492K Hold
14,904
0.2% 85
2014
Q4
$440K Sell
14,904
-105
-0.7% -$3.01K 0.16% 87
2014
Q3
$421K Hold
15,009
0.13% 97
2014
Q2
$423K Buy
15,009
+1,054
+8% +$30K 0.13% 99
2014
Q1
$425K Buy
13,955
+1,318
+10% +$39.3K 0.14% 95
2013
Q4
$367K Hold
12,637
0.12% 97
2013
Q3
$344K Hold
12,637
0.12% 99
2013
Q2
$336K Buy
+12,637
New +$349K 0.1% 101

Other funds holding PFE

Lucas Capital Management's PFE Position: Q4 2020 in Review

Lucas Capital Management opened a new position in Pfizer (PFE) in Q4 2020: 22,371 shares worth $823K. The stake represents 0.96% of the portfolio and ranks #30 among its holdings. This is a return to the name: Lucas Capital Management previously reported a position in PFE as recently as Q4 2018.

Lucas Capital Management first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Lucas Capital Management held 22,371 shares of Pfizer worth $823K as of Q4 2020.
  • Pfizer was a new Lucas Capital Management position in Q4 2020.
  • Pfizer made up 0.96% of Lucas Capital Management's portfolio in Q4 2020, its #30 holding.
  • Lucas Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Lucas Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.